Cite

HARVARD Citation

    Orleth, A. et al. (2016). Simultaneous targeting of VEGF-receptors 2 and 3 with immunoliposomes enhances therapeutic efficacy. Journal of drug targeting. pp. 80-89. [Online]. 
  
Back to record